According to Acumen Research and Consulting, the global coronary artery bypass graft procedures market is expected to grow at noteworthy CAGR around 2.0 % throughout the forecast period and reach around US$ 20 billion by 2026.
Coronary artery bypass grafting can be described as open-heart surgery, where a portion of the ship is grafted from the aorta to the coronary artery in order to overcome the blocked coronary artery segment and enhance the cardiac supply of Blood. Coronary artery bypass surgery graft is a method used primarily in certain conditions to treat coronary artery disease. Coronary artery condition is the reduction in the coronary arteries triggered by the accumulation of fatty material within the artery walls. This accumulation creates a contract within the arteries, limiting the supply of oxygen-rich blood to the heart muscle. Although traditional' open heart ' procedures are still performed and often preferred in many cases, the blocked coronary arteries have been bypassed through less aggressive methods.
Today, the world market of bypass grafts is motivated by the increasing incidence of cardio-vascular illnesses and the growing need for repeat revascularisation in conjunction with geriatric populations.
Cardiovascular diseases are increasing and the population is aging, helping to boost the demand in worldwide markets for bypass grafts. The development of the market for coronary artery bypass graft products is also anticipated to drive the development of endoscopic vessel harvesting systems and anastomosis support systems. But a increasing health budget, bad health reimbursement and payment models, as well as market leaders ' consolidation, constitute a significant obstacle to market development.
The report provides analysis of global Coronary Artery Bypass Graft Procedures market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.
The demand for Coronary Artery Bypass (CABG) interventions is encouraged by factors such as increased incidence of multiple cardiovascular disorders, such as CHD, myocardial infarction and strokes, and the increasing demand for minimally invasive surgery. Furthermore, owing to the better patent pace and longer-term outcomes, technological progress and increasing preference for inner chest thoracic artery graft over saphenous vein graft are projected to boost the CABG procedures industry.
In addition, increasing healthcare expenses boost the financial burden for non-insured patients, because the price of CABG surgery is lower in developing nations. In turn, this is boosting demand in developing countries for medical tourism. Some of the key drivers of demand for CABG processes in developing markets are the availability of advantages like better healthcare, low operating expenses and better hospitality.
The worldwide market for coronary artern bypass graft from 2018 to 2026 will probably be fueled by an increase in the prevalence of cardiovascular illnesses due to stress, obesity, sedentary life and unhealthy habit.
The worldwide market for coronary artery graft bypass is driven by increasing endoscopical operations, an increased incidence of cardiovascular diseases, demographic changes, an increase in complications such as sedentary lifestyle and aging populations and increasing in the field of medical tourism. But the worldwide coronary artery bypass graft market is constrained by the absence of regulatory approvals, increased cardiovascular complications following CABG, and elevated operational costs.
Graft Type Stance
The most frequently used CABG pipeline in 2018 was saphenous vein graft, which held the biggest market share of 40,0%. Elements such as high-flow pipes with a longer graft length, ease of handling and the need for less transfusion compared to other graft kinds form the main factors driving the segment development. Other grafts are anticipated, owing to growing use of the radial artery as the heart attack is considerably less at danger and to repeat revascularizations after an average5-year follow-up, to registrate the highest CAGR of 2,06 per cent between 2019 and 2026. Furthermore, the development in this segment has increased over the forecast period of development in the increasing alternative conduit for Saphenous vein greffing for coronary artery bypass surgery.
Surgery Type Stance
Triple CABG operations in 2018 with three ships bypassed accounted for 31.3% of its biggest market share. It is anticipated that the increase in the incidence of heart disease will be the main driver of demand. From 2019 to 2026 the double CABG operation should be the rapidly increasing sector. The projections are to promote the development of the segment over the forecast period with increasing sophisticated technologies performing double CAGR surgery throughout the world.
North America, with a income of USD 11 billion and anticipated to grow at the CAGR of 2.1 percent at the quickest in the forecast time, headed up the graft operation in coronary artery bypass in 2018. The main reasons for North America's elevated market share include easy access to grafts, elevated healthcare per capita spending, the existence of the target population, inactive lifestyles of people in the United States and Canada, and increased cardiovascular-related death. In the US Coronary Heart Disease accounts for about 13 percent fatalities, which is about 363,452 in 2016, based on estimates released by the American Heart Association. In addition, the growth is expected to be favorably reinforced by favourable CABG repayment policies and related processes and promising federal projects for promoting cardiovascular diseases.
Global Coronary Artery Bypass Graft Procedures Market, By Graft Type
Global Coronary Artery Bypass Graft Procedures Market, By Surgery Type
Global Coronary Artery Bypass Graft Procedures Market, By Geography
The market research study on “Coronary Artery Bypass Graft Procedures Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global Coronary Artery Bypass Graft Procedures market segments with market dynamics and their impact. The report also covers basic technology development policies.
This study offers an assessment of the recent industrial trends in each sub-segment from 2014 to 2026 and forecasts income development at worldwide, regional, as well as national levels. For this research ARC segmented the market survey for coronary artery bypass bypass grafting processes by type, type of surgery and regional sections:
Key Players & Strategies
KARL STORZ GmbH & Co Medtronic, TERUMO Co., are the key players in the worldwide coronary artery bypass graft industry. Other includes KG, Boston Scientific, Ethicon, Neograft, MAQUET Holding, Sorin Group, Boston Scientific. Edwards Lifesciences, and Genesee Biomedical Inc.
These actors implement organic and organic growth strategies for expanding their product portfolio, strengthening geographic scope, increasing their client base and capturing market shares.
Coronary artery bypass grafting can be described as open-heart surgery, where a portion of the ship is grafted from the aorta to the coronary artery in order to overcome the blocked coronary artery segment and enhance the cardiac supply of Blood.
According to Acumen Research and Consulting, the coronary artery bypass grafting market value is anticipated to be worth around US$ 20 billion in 2026.
The global coronary artery bypass graft procedures market is expected to grow at noteworthy CAGR around 2.0 % throughout the forecast period.
The most frequently used CABG pipeline in 2018 was saphenous vein graft, which held the biggest market share of 40,0%.
North America, with a income of USD 11 billion and anticipated to grow at the CAGR of 2.1% at the quickest in the forecast time
Asia Pacific is projected to grow at a fast pace during forecast period in the elastography imaging market.
KARL STORZ GmbH & Co Medtronic, TERUMO Co., are the key players in the worldwide coronary artery bypass graft industry.